@article{fdi:010060509,
  title = {{H}epatitis {B} seroprevalence in {HIV}-infected patients consulting in a public day care unit in {B}obo {D}ioulasso, {B}urkina {F}aso},
  author = {{B}ado, {G}. and {P}enot, {P}. and {N}'{D}iaye, {M}. {D}. and {A}miel, {C}. and {H}ema, {A}. and {K}amboule, {E}. {B}. and {G}uiard-{S}chmid, {J}. {B}. and {K}abore, {N}. {F}. and {S}lama, {L}. and {B}ambara, {A}. and {L}aurent, {C}hristian and {S}angare, {L}. and {S}awadogo, {A}. {B}.},
  editor = {},
  language = {{ENG}},
  abstract = {{O}bjective. - {T}he authors had for aim to assess the prevalence of hepatitis {B} co-infection in a cohort of {HIV}-infected patients, routinely followed-up at the {D}ay {C}are {U}nit of the {B}obo {D}ioulasso {S}anou {S}ouro {U}niversity {H}ospital, {B}urkina {F}aso. {P}atients and methods. - {T}he {E}lisa technique was used to dose {HB}s antigen ({A}g{HB}s), antibodies anti-{HB}s and anti-{HB}c in all the patients followed by the biological laboratory, from {O}ctober to {D}ecember 2008. {R}esults. - {T}he {A}g{HB}s prevalence was 12.7% [{CI} at 95%; 10.7-15.0%] and men were slightly more likely to be positive for {A}g{HB}s than women (16.5% [12.0-21.9%] versus 11.6% [9.4-14.1%]; {P} = 0.047); 83.3% of the patients [80.8-85.6%] were positive for hepatitis {B} core antibody, and 32.6% [29.7-35.6%] for hepatitis {B} surface antibody; 29.9% of the patients [27.1-32.8%] had a complete profile of former hepatitis {B} infection, 41.3% [38.2-44.4%] expressed core antibodies only; 13.8% [11.7-16.0%] had a negative serological test, and 2.3% [1.5-3.4%] presented a vaccinal immunity. {C}onclusion. - {T}hese results stress the usefulness of screening for hepatitis {B} in all {HIV}-infected patients, along with the initial biological tests. {T}his would help adapt {HIV} treatment to co-infected patients and to build an expanded program of vaccination for non-immune patients.},
  keywords = {{HIV}/{HBV} co-infection ; {H}epatitis {B} ; {HBV} surface antigen ; {BURKINA} {FASO}},
  booktitle = {},
  journal = {{M}edecine et {M}aladies {I}nfectieuses},
  volume = {43},
  numero = {5},
  pages = {202--207},
  ISSN = {0399-077{X}},
  year = {2013},
  DOI = {10.1016/j.medmal.2013.04.001},
  URL = {https://www.documentation.ird.fr/hor/fdi:010060509},
}